AstraZeneca (AZN) Insider Trading & Ownership £113.10 +77.88 (+0.69%) As of 12:40 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability AstraZeneca (LON:AZN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.04%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)£2.23 MNumber OfInsiders Selling(Last 12 Months)0 Get AZN Insider Trade Alerts Want to know when executives and insiders are buying or selling AstraZeneca stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AZN Insider Buying and Selling by Quarter AstraZeneca Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/19/2024Tony MokInsiderBuy1,500£126.80£190,20011/14/2024Pascal SoriotInsiderBuy20,000£102.03£2,040,6009/13/2024Michel DemareInsiderBuy2,000GBX 118£2,360 (Data available from 1/1/2013 forward) AZN Insider Trading Activity - Frequently Asked Questions Who is on AstraZeneca's Insider Roster? The list of insiders at AstraZeneca includes Anna Manz, Michel Demare, Pascal Soriot, and Tony Mok. Learn more on insiders at AZN. What percentage of AstraZeneca stock is owned by insiders? 0.04% of AstraZeneca stock is owned by insiders. Learn more on AZN's insider holdings. Which AstraZeneca insiders have been buying company stock? The following insiders have purchased AZN shares in the last 24 months: Anna Manz (£49,625.30), Michel Demare (£338,080), Pascal Soriot (£2,040,600), and Tony Mok (£190,200). How much insider buying is happening at AstraZeneca? Insiders have purchased a total of 26,987 AZN shares in the last 24 months for a total of £2,618,505.30 bought. AstraZeneca Key ExecutivesMr. Pascal Soriot D.V.M. (Age 65)M.B.A., CEO & Executive Director Compensation: $4.57M1 recent tradesDr. Aradhana Sarin M.D. (Age 50)CFO & Executive Director Compensation: $2.52MMs. Pam P. Cheng (Age 54)EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board Mr. Andrew P. BarnettHead of Investor RelationsMr. Jeffrey PottCHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory BoardGonzalo VinaHead of Global Media RelationsDr. Ruud Dobber Ph.D.Executive Vice-President of BioPharmaceuticals Business UnitDr. Susan Mary Galbraith M.D. (Age 58)Ph.D., Executive Vice President of Oncology Research & Development Mr. Leon WangExecutive VP of International & China PresidentMs. Iskra ReicExecutive Vice-President of Vaccines & Immune Therapies More Insider Trading Tools from MarketBeat Related Companies GSK Insider Selling Ithaca Energy Insider Selling Grainger Insider Selling Indivior Insider Selling Bloomsbury Publishing Insider Selling India Capital Growth Insider Selling Alpha Real Trust Insider Selling Pharos Energy Insider Selling Marks Electrical Group Insider Selling CyanConnode Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (LON:AZN) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrillion-Dollar Crypto PlayPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZN Stock Alerts